Evidence map›Paper›PMID 27903937›Full record

ArticleMultiple sclerosis (Houndmills, Basingstoke, England)2017

Identification and validation of clinically meaningful benchmarks in the 12-item Multiple Sclerosis Walking Scale.

Myla D Goldman, Melanie D Ward, Robert W Motl, David E Jones, John H Pula, Diego Cadavid

Registry-linked trialOpen access · greenAbstract readValidation Study
In one paragraph

Article in Multiple sclerosis (Houndmills, Basingstoke, England), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06486116 (Effectiveness of Task Specific Home Exercise Program), which is not on this map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06486116 naunknown statusnot on this mapstarted 2024, after this paper: background citation

Effectiveness of Task Specific Home Exercise Program

TypeinterventionalSponsorNew York Presbyterian Brooklyn Methodist HospitalRan2024 to 2026Enrolled30ConditionsMultiple SclerosisArmsTask Specific Physical Therapy Home Program
3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 42 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Measuring health-related quality of life in multiple sclerosis: comparing the acceptability, validity and responsiveness of the EQ-5D-3L and MSIS-8D.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Mediterranean diet is linked to less objective disability in multiple sclerosis.Multiple sclerosis (Houndmills, Basingstoke, England) · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Myla D GoldmanDepartment of Neurology, University of Virginia School of Medicine, Charlottesville, VA, USA.
Melanie D WardDepartment of Neurology, University of Virginia School of Medicine, Charlottesville, VA, USA.
Robert W MotlDepartment of PT, School of Health Professions, University of Alabama at Birmingham, Birmingham, AL, USA.
David E JonesDepartment of Neurology, University of Virginia School of Medicine, Charlottesville, VA, USA.
John H PulaCollege of Medicine at Peoria, University of Illinois, Peoria, IL, USA.
Diego CadavidBiogen, Cambridge, MA, USA.
University of Virginia · USBiogen (United States) · USPeoria campus of the University of Illinois System · USUniversity of Alabama at Birmingham · US

Funding

Validation of a Motor Fatigue Measure in Multiple SclerosisK23NS062898 · NINDS · UNIVERSITY OF VIRGINIA · PI GOLDMAN, MYLA DENISE · 2009 to 2013
$878k
NINDS NIH HHS K23 NS062898
6 · The paper itself

Abstract

backgroundThe 12-item Multiple Sclerosis Walking Scale (12-MSWS) is a validated questionnaire which assessed walking function; it has been widely adopted in multiple sclerosis (MS) clinical research.

objectiveIdentify and validate clinically meaningful 12-MSWS benchmarks in MS.

methodsCross-sectional study of 159 MS patients permitted identification of clinically meaningful 12-MSWS benchmarks based on their relationship to real-life anchors. Identified 12-MSWS benchmarks were then validated in a second population of 96 subjects using measures of ambulation, cognition, and patient-reported outcomes.

results12-MSWS score of 0-24.99 was associated with working outside the home and assistance-free mobility; 25-49.99 was associated with gait disability and difficulty doing housework; 50-74.99 was associated with unemployment, government healthcare, cane use, and difficulty performing instrumental activities of daily living (IADLs); and 75-100 was associated with change in occupation due to walking, mobility impairment requiring bilateral assistance, and inability to perform IADLs. During the validation step, strong linear associations were identified between 12-MSWS benchmarks and other MS-related disability outcome measures, including ambulatory and non-ambulatory measures.

conclusionWe have identified clinically meaningful 12-MSWS benchmarks which define four groups differentiated by increasing levels of mobility impairment and associated loss of functional independence. These data provide insight into how 12-MSWS translate to meaningful functional limitations in MS.

Indexed as

Disability EvaluationAdultBenchmarkingCross-Sectional StudiesFemaleHumansMaleMiddle AgedMultiple SclerosisSurveys and QuestionnairesWalkingclinically meaningfulMSWSMultiple sclerosisoutcome researchwalking impairment

Identifiers

PMID27903937
PMCPMC5411321
OpenAlexW2557441574

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.